paclitaxel-associated LDL-like nanoparticles
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for paclitaxel-associated LDL-like nanoparticles, covering 2020-10-27 to 2020-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles [Phase 2, Phase 3]